The AIMP1 gene helps cells make proteins and supports healthy brain and nerve function. If it does not work properly, the brain’s white matter, the insulating layer that helps nerve signals travel, may not develop or hold up as expected. People with more disruptive variants in both copies of the AIMP1 gene can have developmental delay, low muscle tone, movement problems, seizures, and intellectual disability.

What is a gene?

Genes are stretches of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others are mainly involved in directing when specific processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence responses to food, stress, and medicines. More detailed information is available in LearnHub.

Overview

AIMP1

Gene function

What if the gene works

The AIMP1 gene helps your cells make proteins by supporting a larger complex involved in this process. Its protein also takes part in cell signaling that helps tissues grow, repair, and respond to stress.

Risk

What if the gene does not work

More disruptive variants in the AIMP1 gene can cause an early-onset brain white matter condition with developmental delay, low muscle tone, movement problems, seizures, and sometimes a smaller head size; milder variants may lead to less severe neurodevelopmental problems.

Treatment

What does that mean for your treatment

For people with a pathogenic variant in the AIMP1 gene, no AIMP1-specific treatment or drug-selection approach is currently established, so care is guided by the person’s symptoms and overall clinical needs rather than by the gene change itself.

Conditions associated with AIMP1

Autosomal recessive non-syndromic intellectual disabilityPelizaeus-merzbacher-like disease due to aimp1 mutation

Gene function

What if the gene works

AIMP1 helps your cells keep protein production organized. Its protein acts like a coordinator for several enzymes that prepare amino acids for use in new proteins. This steady support matters in everyday cell work, from growth to repair. In simple terms, the AIMP1 gene helps cells make proteins in a controlled, efficient way.

Enzyme teamwork

Inside your cells, the AIMP1 gene helps organize a group of protein-making enzymes into one working unit. Keeping these enzymes together can make everyday protein production more steady and efficient.

Amino acid loading

Its protein supports the step where amino acids are matched to transfer RNAs, the small carriers used during protein building. This helps cells place the right building blocks into new proteins at the right time.

Protein reading

The AIMP1 gene supports translation (the step where cells read RNA instructions to build proteins). This helps many tissues keep up with routine needs such as growth, upkeep, and repair.

What is a variant?

A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not produce any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the AIMP1 gene can change the protein’s shape, make it less stable, or stop the cell from making enough of it. Some milder variants leave partial activity, while more severe variants, especially changes that cut the protein short, can cause major loss of function and weaker interactions with partner proteins inside the cell. This spectrum helps explain how AIMP1 gene variants affect the protein and why established AIMP1-related neurologic conditions may begin earlier and be more pronounced in some people.

How variants are linked to conditions

Rare, usually biallelic pathogenic variants in the AIMP1 gene cause hypomyelinating leukodystrophy type 3, a condition affecting brain development and movement. Children with this AIMP1 gene condition often have early developmental delay, low muscle tone at first, and later muscle stiffness, with brain MRI changes that fit reduced myelin. Finding disease-causing variants in both copies of the AIMP1 gene can confirm the diagnosis.

A variant is not necessarily a diagnosis

Gene variants are a routine part of human biology and are common across the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

For AIMP1-related conditions, risk is mainly shaped by inherited gene changes rather than lifestyle. Risk is higher when both biological parents carry a harmful change in the AIMP1 gene, and it can also be higher in families with known AIMP1-related conditions or when parents are blood relatives.

Inheritance of AIMP1 variants

AIMP1-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one AIMP1 gene variant from each parent, and parents who each carry one variant are often unaffected themselves. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of inheriting neither variant. In families learning how AIMP1 gene variants are inherited, this parent-to-child pattern is the key point.

What does my AIMP1 result mean for my family?

For families with an AIMP1-related condition, relatives may also carry the changed gene even if they do not have symptoms. Brothers and sisters of an affected child may have the same condition or be carriers, and other close blood relatives may also be carriers. Family members often think about carrier testing when this kind of result is found.


Genetic information


Genetic testing

How you find out about variants

Genetic testing for variants in the AIMP1 gene usually analyzes DNA from a blood sample or cheek swab. A lab reads the gene’s sequence and compares it with a reference sequence to look for changes, which can help confirm whether a person carries an AIMP1 variant linked to an inherited condition.

When should I consider getting a genetic test?

Genetic testing for the AIMP1 gene may be worth considering when a baby or child has severe developmental delay, weak muscle tone, seizures, or brain scan findings that suggest a rare inherited condition affecting the brain’s white matter. It can also be helpful if there is a known AIMP1 variant in the family or a history of similarly affected children.

A genetic result is only one part of your health story

Genetic results can offer insight, but what they tell you depends on the condition and the type of variant involved. Many factors, including age, lifestyle, environment, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is understood alongside other aspects of care. In other cases, a genetic result may give an answer. In areas like medication response, results can help put individual experiences in perspective.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how your body responds to medicines. People can process the same drug at different speeds, which may change how well it works or how likely side effects are. This kind of variation is common and is one reason a treatment that helps one person may feel too strong, too weak, or less effective in another.

What is Pharmacogenetics?

Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene drug patterns to help explain why the same treatment may work differently in different people. With many medicines, genes can influence both how powerfully a drug works and how the body handles it. This information can support treatment decisions that are better informed and more individualized. To look into this subject further, more information is available in the LearnHub.


Drugs influenced by the AIMP1 gene

There are 0 Drugs associated with AIMP1
Currently no available information

When should I seek medical advice?

There is no broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or other health concerns are best discussed with your doctor.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved